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Background: Domestic violence and abuse (DVA) are associated with an increased risk of mental illness, but we
know little about the mental health of female DVA survivors seeking support from domestic violence services.
Objective: To characterize the demography and mental health of women who access specialist DVA services in
the United Kingdom and to investigate associations between severity of abuse and measures of mental health
and health state utility, accounting for important confounders and moderators.
Design: Baseline data on 260 women enrolled in a randomized controlled trial of a psychological intervention
for DVA survivors was analyzed. We report prevalence of and associations between mental health status and
severity of abuse at the time of recruitment. We used logistic and normal regression models for binary and
continuous outcomes, respectively. Mental health measures used were: Clinical Outcomes in Routine
EvaluationOutcome Measure (CORE-OM), Patient Health Questionnaire, Generalized Anxiety Disorder
Assessment, and the Posttraumatic Diagnostic Scale (PDS) to measure posttraumatic stress disorder. The
Composite Abuse Scale (CAS) measured abuse.
Results: Exposure to DVA was high, with a mean CAS score of 56 (SD 34). The mean CORE-OM score was
18 (SD 8) with 76% above the clinical threshold (95% confidence interval: 7081%). Depression and anxiety
levels were high, with means close to clinical thresholds, and all respondents recorded PTSD scores above the
clinical threshold. Symptoms of mental illness increased stepwise with increasing severity of DVA.
Conclusions: Women DVA survivors who seek support from DVA services have recently experienced high
levels of abuse, depression, anxiety, and especially PTSD. Clinicians need to be aware that patients presenting
with mental health conditions or symptoms of depression or anxiety may be experiencing or may have
experienced DVA. The high psychological morbidity in this population means that trauma-informed
psychological support is needed for survivors who seek support from DVA services.
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T
he reported lifetime prevalence of physical or sexual
intimate partner violence (IPV), or both, for ever-
partnered women varies globally from 15 to 71%;
and the 12-month prevalence rates vary from 4 to 54% (1).
One in five women aged 15 years or older has ever
experienced IPV in Europe; 4% have experienced it in the
past year (2). IPV is associated with depression, anxiety,
posttraumatic stress disorder (PTSD), and substance
abuse in the general population (35), and among women
consulting in primary care (6, 7). There is evidence for a bi-
directional effect (i.e. that women experiencing abuse are at
greater risk of mental health conditions and that having a
mental health condition makes one more vulnerable to
abuse) particularly for depression, although there is a
shortage of longitudinal studies to partition the directions
of this effect (3). Qualitative research with survivors of IPV
highlights the impact of abuse on the development of
mental health problems (8). The few studies that investi-
gate the association between severity of exposure to IPV
with mental and physical health problems report positive
associations (911). In these studies, the strength of
association differs by type of abuse (912). Furthermore,
Hegarty and colleagues (9) find that severe abuse is
consistently associated with worse social coping, as well as
increased levels of anxiety and posttraumatic stress symp-
toms. Abuse is also associated with poor self-reported
physical health and pain, injuries, gynecological and ob-
stetric conditions, and difficulties carrying out daily activities
(5, 13). Severity and type of PTSD (14) are also predicted
by exposure to childhood abuse or maternal IPV (3).
Moreover, women who have recently experienced severe
episodes of violence generally experience high levels of
distress (9). Female survivors of IPV who seek advocacy
support report high levels of abuse and depression when
they first contact services (15, 16), higher than the general
population (17). These decrease in time, independently of
whether women are offered treatment or not (18, 19), and
depression rates in women who have left the violent
relationship up to 1 year earlier are similar to those in the
general population (4).
Age may be a confounding factor in the relationship
between exposure to IPV and mental health. Although
younger women are at a greatest riskof current abuse, older
women have a greater lifetime experience; both current and
lifetime experience increase the risk of mental health
problems. Higher education and employment status are
probably protective factors against IPV exposure (20, 21,
22). Socioeconomic status, as well as recency and duration
of abuse, therefore needs to be included in any analysis of
the relationship between IPV exposure and mental health.
In this study, we aim to 1) characterize the demography
and mental health of women who access specialist do-
mestic violence and abuse (DVA) services in England and
Wales; 2) investigate associations between the severity of
abuse and measures of mental or physical health and
quality of life, taking into account important potential
confounders such as age and socioeconomic status, as well
as important potential moderators such as exposure to
direct maltreatment as a child (7, 15, 23), and prior history
of mental health problems (3, 4).
Methods
Study setting and design
This study uses data from a cross-section of 260 women
seeking help from two DVA services in the voluntary
(non-statutory) sector in two UK cities, Bristol and
Cardiff. Study participants were women recruited to the
PATH (psychological advocacy toward healing) rando-
mized controlled trial testing the effectiveness and cost-
effectiveness of a novel psychological intervention for
survivors of DVA. Treatment is delivered by advocates or
support workers called specialist psychological advocates
(SPAs) in view of the specialization they gained through
the PATH training. Here we present findings from the
baseline data we collected at recruitment. Sample size was
determined by the need to detect reliable change in the
main outcomes of the PATH trial (24). In this paper, the
precision of the analysis is indicated by the confidence
intervals of the estimated prevalence and associations.
Eligible participants were women who were experien-
cing domestic violence or abuse which led them to seek
support from a DVA agency in Bristol or Cardiff between
11 April 2011 and 4 June 2013, and were 16 years or older.
This included women who had experienced IPV or abuse
(psychological, physical, sexual, or financial) from adult
family members. Their first point of contact with the
agencies, a support worker, screened them for other
exclusion criteria: 1) psychotic illness; 2) severe drug
or alcohol problem; 3) inability to read English; and
4) current counselling, cognitive behavioral therapy, or
other psychological treatments either in primary care or
specialist psychiatric services.
Eligible women willing to discuss participation in the
study were then contacted by a researcher who sought
consent. At that meeting, women who consented to par-
ticipation self-completed the baseline questionnaire on
which this paper is based.
Data collection
The PATH baseline questionnaire contained validated
measures of mental health and exposure to abuse from
either an intimate partner, a member of the woman’s
family, or another adult. It also contained questions on
socioeconomic variables including age, parity, and em-
ployment status; substance use and general health vari-
ables; and measures of childhood exposure to abuse and
maltreatment (23). A researcher was present in the room
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when the women filled in the questionnaire to provide
assistance if requested.
Measurement
We used six scales to measure mental health (see Supple-
mentary file). Symptoms of psychological distress are
captured with the Clinical Outcomes in Routine Evalua-
tion  Outcome Measure (CORE-OM), which measures
symptoms of psychological distress in four domains:
subjective well-being, problems and symptoms, function-
ing, and risk to self or others (25). CORE-OM is a stan-
dard screening measure in counselling services across the
United Kingdom (25), and there are normative values
from general and clinical populations in the United
Kingdom. We use the continuous clinical CORE-OM
score, with values between 0 and 40 (25).
We measure symptoms of depression with the 9-item
version of the Patient Health Questionnaire (PHQ-9). The
PHQ-9 is used routinely in general practice in the United
Kingdom to screen for symptoms of depression, and there
are normative values for both clinical and general popula-
tion (26). We computed an indicator equal to 1 if the PHQ-
9 score was greater than 9, that is, suggestive of major
depression (27). Symptoms of anxiety were measured with
the 7-item Generalized Anxiety Disorder questionnaire
(GAD7) (28). We computed an indicator equal to 1 if the
GAD7 score was greater than 9. We measured posttrau-
matic stress with Weathers’ Posttraumatic Stress Disorder
Check List (29). In our analysis we use a continuous
measure of the PTSD score, because all women in our
sample record a PTSD value at least equal to 17, the
threshold that diagnoses posttraumatic stress (14). The
EuroQol EQ5D-5L (30) measured health state utility on a
scale from less than 0 (worse than dead) and 1 (perfect
health). Finally, we measured quality of life with the SF-12,
a measure of health status. Specifically, we computed the
SF-12 aggregate mental and physical health subscales,
which capture respondents’ physical and emotional health
state and whether these interfere with their daily lives and
activities (31)
The measure of DVA was the Composite Abuse Scale
(CAS). The CAS is a 30-item self-reported measure
capturing emotional, physical, and severe abuse, as well
as harassment (32). For our analysis we used a continuous
version of the score, which can range between 0 and 150
(see Supplementary file). We preferred the continuous
score to the binary (cut-off score: CAS]3) because of the
high IPV exposure in our sample.
Recency of exposure was summarized by an ordinal
variable that assigned higher values to more recent events.
It varies between 0 (more than 12 months ago) and 4 (in the
past month). Length of exposure varies between 1 (one
occasion) and 6 (for more than 5 years), similarly increas-
ing in the length of exposure. We summarized childhood
abuse with avariable equal to 1 if the respondent had either
been the victim of physical or sexual abuse in childhood.
We also included abinary variable that denotes exposure to
domestic abuse from a family member who is not an
intimate partner, in order to account for exposure to
multiple forms of abuse. Past mental health issues were
self-reported by the women: the questionnaire asked
whether they had experienced mental health problems
such as depression or anxiety in the past. We coded all
positive responses to this question as 1, and attributed a 0
score to all women who reported no problems. We used
binary variables to capture whether the women had
children younger than 4 years of age living with them,
and whether they were in a relationship. The indicator for
cannabis use was set to 1 if the woman had been using
cannabis in the previous 12 months. For alcohol consump-
tion we constructed a measure of binge drinking on a
typical drinking day based on the women’s responses to the
AUDIT measure in the questionnaire (33). For women, the
UK National Health System (NHS) defines binge drinking
as more than six units a day, so our indicator is equal to 1 if
the respondent reported drinking more than six units on a
typical day when she drank. Women’s age was measured in
years; their educational attainment with a categorical
measure varying between 0 (no education) and 5 (bache-
lor’s degree or higher); and their employment status with a
binary variable equal to 1 if the interviewee was not in
work, that is, either unemployed, a student, or a retiree.
Analysis
The data from the questionnaire were entered in an
Access database. The CORE-OM and PHQ-9, together
with the urban center and type of service variables, were
entered twice independently to ensure accuracy. Consis-
tency and logical checks were performed in Access.
All analyses were conducted in Stata 12.1 (34). We
characterize the sample with descriptive statistics of all
variables.
For continuous variables, coefficients and 95% confi-
dence intervals are calculated with normal regressions. For
binary variables, odds ratios and 95% confidence intervals
are calculated with logistic regressions. We report the
univariable odds ratios (coefficients) with 95% confidence
intervals for associations between mental health and
exposure to abuse. The odds ratio (coefficient) and 95%
confidence intervals of the adjusted estimates account for
age, education, employment status, relationship status, the
presence of children younger than 4 years of age, as well as
alcohol and drug use, and help-seeking for mental health in
the past (35). We also adjust for non-IPV domestic abuse
and childhood abuse, as well as recency and duration of
exposure. To investigate whether recency, duration, or
child maltreatment modify the association between ex-
posure and mental health, we also test for multiplicative
effects (data available upon request). All adjusted esti-
mates also account for site (Bristol, Cardiff) and service
Domestic violence and mental health
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type (refuge, outreach services) to reflect stratification in
the sample (24). We present a complete case analysis, so
that all women who had not reported a value for one of the
variables in the model were excluded from the analysis. The
number of respondents used to compute the statistics is
always reported. We also exclude from analysis the seven
women (out of 251) who reported experiencing DVA only
from other family members, and not from intimate partners.
Ethical considerations
The study was approved by the South West National
Research Ethics Service with specific approvals being
received from appropriate local research ethics commit-
tees. Informed consent was sought from each woman
during the first meeting, before she filled in the question-
naire, and the research assistant offered support in case of
distress while the questionnaire was being completed.
Results
The participating DVA services reported a total of 1,940
women requesting support during the recruitment period.
We screened 66% of these women and 1,096 (86%) were
eligible. Of these, 792 (72%) were approached and 263
(33%) recruited into the study. Three withdrew, and 260
completed a baseline questionnaire: 13% of the women
who originally requested support (Table 1). Language
barriers and being in receipt of a psychological treatment
Table 1. Recruitment into study by site and service
Cardiff Bristol Total
Women’s
center
Community
outreach Residential Total
% of
entered
Community
outreach Residential Total
% of
entered N
% of
entered
Entered service 444 534 317 1,295 519 126 645 1,940
Screened 162 408 209 779 60 372 121 493 76 1,272 66
Ineligible 31 73 20 124 10 49 30 79 12 203 10
Drug & alcohol 6 9 1 16 7 0 7 23 1
Language
barrier
14 14 7 35 20 27 47 82 4
Male 1 0 0 1 0 0 0 1 10
Psychotic 1 5 1 7 7 0 7 14 1
Psychological
therapy
9 46 11 66 15 3 18 84 4
Eligible but not
approached
115 51 52 218 17 67 19 86 13 304 16
One-off contact 29 0 0 29 29 1
SPA capacity 60 53 42 155 50 17 67 222 11
Researcher
capacity
22 8 6 36 14 1 15 51 3
Other 4 19 4 27 3 1 4 31 2
Unable to contact/
declined
4 59 58 121 9 65 10 75 12 196 10
Approached 16 284 137 437 34 274 81 355 55 792 41
Did not consent to
contact
6 117 15 138 11 115 26 141 22 279 14
Consented to
contact
10 167 122 299 23 159 55 214 33 513 26
Met with
researcher
6 108 64 178 14 92 45 139 21 317 16
Recruited 4 95 47 146 11 86 31 117 18 263 14
Not recruited 2 13 17 32 2 6 6 12 2 44 2
Wanted
counseling
1 2 3 6 0  0 6 0
Time
commitment
1 6 5 12 2 2 4 16 1
Other 0 5 9 14 4 4 8 22 1
Withdrawal    0 3 1 4 3 0
Total 4 95 47 146 11 84 30 114 18 260 13
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accounted for 55% of ineligible cases (9% of initial
throughput); time commitment represented the most
common single reason why women declined recruitment
after having been offered inclusion in the study.
For 26 of the 28 variables used in this analysis less than
10% of values are missing. The variable with the highest
percentage of missing values is income (40%). In this paper,
we present the complete case analysis, and therefore exclude
income from the variables in our model, as we have two
other measures of socioeconomic status: level of education
and employment. The women in our sample were 33 years
old on average (Table 2); the majority had gained a city and
guilds diploma; two-thirds were not in formal employment.
Almost 70% of women report severe abuse, with an over-
all average score of 57 on the continuous CAS measure
(Table 3). Abuse episodes were relatively recent and had been
sustained over time for the majority of women. Seven
out of 251 women reported being victims of domestic
abuse from another member of the family and not from
an intimate partner (2.8%; 95% confidence interval: 1.0%
to 4.5%).
Two-thirds of the women reported clinical levels of
psychological distress, with total CORE-OM averaging at
18 points (standard deviation: 7). At least 70% of women
reported clinical levels of distress in all subareas of the
CORE-OM, as well as depression and anxiety symptoms
(Table 4). Of 256, 197 women (77%; 95% confidence inter-
val: 71.2% to 82.9%) scored at least 17 points on the PTSD
measure, the optimal threshold to identify this disorder (14);
and 211 out of 256 (82%, 95% confidence interval: 77.6%
to 87.1%) at least 15 points, the recommended cut off point
in Sheeran and Zimmerman (2002, in (14)). The measure
of health state utility records a value of 0.6 (standard
deviation: 0.3). Women in the general UK population have
average EQ5D values between 0.81 and 0.94 in the age
groups below 64, and never lower than 0.71 in older women
(36). Finally, quality of life measures suggest somewhat
worse mental and physical health states compared to the
general US population (31).
The crude associations of severity of exposure to abuse
with mental health distress and trauma are strong (correla-
tion coefficient: 0.3 and 0.4 respectively, pB0.0001 in both
cases); as is that with health state utility (0.3, pB0.0001).
Women who report symptoms of depression report an
average abuse score of 61 (standard deviation: 33); compared
to an average of 43 (standard deviation: 30) for women who
do not report depression symptoms. Similarly, women who
record symptoms of anxiety record and average exposure
score of 61 (standard deviation: 34), compared to an average
of 46 (standard deviation: 30) for women with no reported
symptoms of anxiety. In the section below we report results
from linear and logistic regressions of mental health states on
exposure to abuse, controlling for modifiers and socio-
demographic characteristics.
Table 5 shows positive associations between exposure
to abuse and psychological distress, and negative associa-
tions between health state utility and quality of life and
abuse, all measured with good levels of precision, except
for the mental health subcomponent of the SF-12.
The severity of psychological distress increases with
severity and extent of abuse: for every additional point in
the abuse score, women report a 0.081 points increase in
Table 2. Sociodemographic profile of the sample
Mean Median % Minimum Max Standard deviation (IQR) N
Age 33 31 18 63 17 248
Maximum education level (City & guilds
and similar)
None Bachelor’s degree
or higher
(GCSE to A-level) 233
Income bracket Up to £10,999 Up to
£10,999
More than £60,000 (Up to £10,999£11,000
£20,999)
156
White 87 34% 253
Currently in a relationship 20 40% 250
Perpetrator is current partner 23 42% 236
Is a parent 81 39% 254
Has children under 4 years of age 37 48% 260
Works in the household 38 49% 237
Not in formal employment (excl retirees
and students)
78 42% 236
Binges when she drinks 15 36% 251
Smoked cannabis in past 12 months 26 44% 245
Witnessed DVA as a child 52 50% 257
Was abused as a child 50 50% 257
Had a mental health problem in the past 82 38% 251
Domestic violence and mental health
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the score of psychological distress (pB0.0001). Control-
ling for moderators such as childhood abuse, which
increases the likelihood of exposure to abuse in adulthood
(37), and sociodemographic characteristics, slightly in-
creases the size of this association without changing the
precision of the estimate.
Table 3. Exposure to abuse
CAS measure
Mean Median % SD Minimum Maximum Inter quartile range N
Severe abuse 6 3 8 0 33 248
Emotional abuse 31 31 16 0 55 248
Physical abuse 13 11 10 0 35 248
Harassment 8 7 6 0 20 247
Total abuse 57 49 34 0 136 245
Severe abuse 1 69 46% 248
Emotional abuse 3 96 20% 248
Physical abuse 1 92 28% 248
Harassment 2 86 35% 247
Total abuse 3 97 18% 245
Type of abuse, ordinal
measure
Severe combined
abuse (SCA)
None SCA (Physical and
others  SCA)
251
Recency In the past 3 months More than 1
year ago
Past month Between 6 and less
than 1 month ago
243
Length of exposure Up to 3 years Never More than 5
years ago
Up to 1, to more than
5 years
244
Table 4. Mental health, health utility, and quality of life measures
Mean SD Median Minimum Maximum N
CORE-OM
Subjective well-being 24 8 25 3 40
Percentage with mean ]1.77 75% 259
Problems 22 10 23 0 40
Percentage with mean ]1.62 70% 259
Functioning 20 8 20 2 36
Percentage with mean ]1.3 80% 259
Risk 4 7 0 0 30
Percentage with mean ]0.31 40% 259
CORE-OM 18 7 19 2 35
Percentage with mean ]1.29 76% 259
Depression, anxiety, stress
Depression (phq9) 14 7 14 0 27
PHQ9 score 9 72% 258
Anxiety (gad7) 13 6 14 0 21
GAD7 score 9 70% 255
Posttraumatic stress (Posttraumatic Diagnostic Scale (PDS)) 26 12 27 0 50
PTSD score ]17 77% 256
Utility
EQ5D-5L 0.6 0.3 0.7 0.2 1.0 249
Quality of life
SF-12 aggregate physical health 48 12 51 19 68 236
SF-12 aggregate mental health 31 14 30 6 62 236
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The unadjusted association between exposure to abuse
and posttraumatic stress is positive, with the measure of
PTSD increasing 0.2 of a point for every unit increase in the
measure of exposure to abuse (pB0.0001). The size of this
association is unchanged when we control for moderators
and demographic characteristics.
Both measures of health state utility decrease as severity
to exposure increases (pB0.001), with precision decreasing
only for the mental health sub-component of the SF-12,
once sociodemographic confounders are accounted for
(p0.001).
Associations between increasing exposure to abuse,
and symptoms of depression or anxiety are also positive
and precisely estimated (Table 6).
Unadjusted odds ratios suggest a small positive asso-
ciation between exposure to abuse and depression (odds
ratio 1.02; 95% confidence interval 1.01 to 1.03). Adjust-
ing for confounders leaves the association unchanged.
The associations with anxiety and PTSD are more
precisely estimated than the one with depression. The
univariable association between exposure and the mea-
sures of anxiety and posttraumatic stress are positive.
Controlling for moderators and other socioeconomic
variables suggests that the odds of being anxious or
suffer from posttraumatic stress increase by 3% for every
additional point in the score of exposure to abuse (95%
confidence interval 1.02 to 1.05, and 1.01 to 1.04,
respectively).
In our analyses, none of the tests for interactions
between severity of abuse and recency, length of exposure,
and child maltreatment were statistically significant (data
available from authors).
Discussion
Half of the women in our sample of IPV survivors had
been exposed to IPV for up to 3 years, and had experienced
the last episode in the 3 months prior to getting in touch
with the services. Half had been abused as children and
more than four in five had had a mental health problem in
the past. More than three quarters reported symptoms of
Table 5. Associations between mental health and health
state utility and severity of exposure to violence
Variable Coefficient Adjusted coefficient
Measures of mental health
COREOM 0.081 0.1
95% CI (0.062, 0.10) (0.063, 0.1)
p B0.0001 B0.0001
N 245 174
PTSD 0.2 0.2
95% CI (0.1, 0.2) (0.1, 0.2)
p B0.0001 B0.0001
N 243 172
Measures of health state utility
EQ5D 0.0028 0.0038
95% CI (0.0034, 0.0022) (0.0047, 0.0029)
p B0.0001 B0.0001
N 238 170
Quality of life
Aggregate physical
health (T Score)
0.080 0.096
95% CI (0.11, 0.055) (0.14, 0.053)
p B0.0001 B0.0001
N 228 165
Aggregate mental
health (T Score)
0.10 0.12
95% CI (0.15, 0.055) (0.19, 0.047)
p B0.0001 0.001
N 228 165
The first column of results reports coefficients from a normal
univariable regression of the mental health or utility variable
(COREOM, PTSD, EQ5D, and physical and mental health sub-
scales of the SF-12) on exposure to abuse as captured by a
continuous measure of the Composite Abuse Scale (CAS); the
second column reports coefficients from a regression of the
same mental health and quality of life measures on CAS, and
sociodemographic confounders (age, number of live-in children
under 4, maximum level of education, use of drugs and alcohol,
and work status) as well as measures of recency and length of
exposure, previous mental health issues, exposure to non-ipv
domestic abuse, and exposure to child abuse.
Table 6. Association between binary mental health states
and severity of exposure to violence
Variable Odds ratios Adjusted odds ratios
PHQ99 1.02 1.02
95% CI (1.01, 1.03) (0.99, 1.05)
p 0.002 0.002
N 244 174
GAD79 1.02 1.03
95% CI (1.01, 1.02) (1.02, 1.05)
P B0.0001 B0.0001
N 241 174
PTSD]17 1.03 1.03
95% CI (1.02, 1.03) (1.02, 1.04)
P B0.0001 B0.0001
N 243 172
The first column of results reports odds ratios from a univariable
logistic regression of the mental health variable (PHQ9, GAD7,
PTSD) on exposure to abuse as captured by a continuous
measure of the Composite Abuse Scale (CAS); the second
column reports adjusted odds ratios from a logistic regression
of PHQ9, GAD7 and PTSD on CAS, and sociodemographic
confounders (age, number of live-in children under 4, maximum
level of education, use of drugs and alcohol, and work status) as
well as measures of recency and length of exposure, previous
mental health issues, exposure to non-ipv domestic abuse, and
exposure to child abuse.
Domestic violence and mental health
Citation: Glob Health Action 2014, 7: 25519 - http://dx.doi.org/10.3402/gha.v7.25519 7
(page number not for citation purpose)
D
ow
nl
oa
de
d 
by
 [L
on
do
n S
ch
oo
l o
f H
yg
ien
e &
 T
ro
p M
ed
ici
ne
] a
t 1
3:0
2 2
6 O
cto
be
r 2
01
7 
PTSD at the time they filled in the questionnaire. This is
consistent with Howard and colleague’s systematic review
of epidemiological studies of diagnosed mental illness that
reported the risk of PTSD as higher among women
exposed to IPV than any other mental health condition.
This is an important finding for clinicians, particularly
generalists, who often miss the symptoms of PTSD in the
context of domestic violence (38). Given the ubiquity and
severity of PTSD resulting from IPV (39), health services
need to develop and implement specific IPV trauma
interventions for survivors.
The participants in our study have substantially more
psychological distress, as measured by the CORE-OM,
than the general and clinical populations of women in the
United Kingdom. Their average score is almost four times
higher than women in the general population, whose
mean value is 4.8, and similar to women seeking
psychological therapies in primary and secondary care,
whose mean is 18.6 (40). The proportion of women who
present symptoms of depression in our sample is twice as
large as that of women in UK general practice (26); for
symptoms of anxiety, this proportion is three times
as large (28). This profile is consistent with previous
findings on women who seek advocacy support in the
United States (15, 16) and Hong Kong (17).
Also consistent with other studies, we found that in-
creasing severity of IPV was associated with worse mental
health (10, 11, 35), especially anxiety and PTSD, even after
controlling for confounders. In our population, exposure
to recent IPV has a stronger association with symptoms of
mental illness than other known predictors: exposure to
child maltreatment (3, 15), heavy drinking (22), or drug
abuse (41), as well as a history of poor mental health.
Presentation of symptoms of mental illness in generalist
or psychiatric practice should be considered a potential
indicator of past or current IPV, or possibly non-partner
domestic violence. It should prompt questions about
abuse, as recommended in the WHO guidelines on intimate
partner and sexual violence: ‘[H]ealth-care providers
should ask about exposure to intimate partner violence
when assessing conditions that may be caused or compli-
cated by intimate partner violence’ (42) including symp-
toms of depression, anxiety, PTSD, sleep disorders,
suicidality, or self-harm.
We found a very small negative association between
increasing exposure to DVA and our health-related utility
measure. One explanation for this may be that this
measure is not appropriate for capturing the health and
quality-of-life-related impacts of exposure to DVA in a
highly traumatized population. For example some of the
domain-specific items in the EQ5D, such as ‘I have [slight/
moderate/severe] problems washing or dressing myself’
are not likely to be relevant to this population.
Strengths of our study include focusing on women who
are seeking help for DVA; providing a basis for designing
interventions for that group; relatively precise estimates
of the association between DVA severity and symptoms
of mental illness; and the relatively low proportion of
missing data with the exception of income that we replace
with education level and employment status to include
socioeconomic status in the analysis. These two variables
are positively associated with income in the general
population.
A limitation of our study is that the women in our
sample are a minority of the women who presented at the
participating DVA services and may differ from the women
who were not eligible for the trial, were not approached, or
declined to participate. In terms of the main findings of
our study  the high proportion of survivors of IPV with
symptoms of mental illness and the association of these
symptoms with severity of violence  it is likely that the
potential bias is in a conservative direction: women
receiving psychological therapy or with psychotic symp-
toms (5% of women expressing interest in participation)
were excluded. However, as potential participants were
being offered psychological therapy in the context of the
trial, it is likely that women with more psychological
distress would be more likely to consent. A more general
limitation is that our findings cannot be extrapolated to
the whole population of women who have experienced
DVA, as only a minority seeks help from DVA services.
Overall, our findings are consistent with other stud-
ies on the association between IPV and mental health
problems.
The high mental health morbidity among women
seeking support from DVA services highlights the need
for effective, trauma-informed support services for this
population. Equipping non-specialist support workers
with psychological skills in advocacy agencies to support
survivors of IPV may represent an important avenue for
improving survivors’ well-being (43). Furthermore, parti-
cularly in resource-poor settings, skilling up non-specialist
and non-medical personnel to deliver psychosocial sup-
port to women survivors of DVA may help engage hard-
to-reach populations in a sustainable service framework.
Were such interventions effective, they would very likely
be cost-effective at improving survivors’ well-being, given
the high cost of IPV to individuals, health services, and
society as a whole (44).
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